Sanalkons is a clinical decision support system offered to users with a license model, where doctors can easily reach differential diagnoses during the diagnosis process, make more accurate and faster decisions, and instantly access location-based information and surrounding public health data.
According to the data of the WHO, the first reason for the errors made in the diagnosis of the disease originated from the general practitioners. WHO also states that the solution lies in systems that offer differential diagnosis.
Our product has been offered to dozens of doctors during the testing phase. In this process, where the beta version is tested, necessary arrangements are made in line with the user experience. Our product is technically 95% ready for sale and plans to complete all its deficiencies and go on sale on August 30.
The first targeted and potential customers are general practitioners in Turkey. According to 2018 World Health Organization (WHO) data, the number of general practitioners in Turkey is 44,311.
Annual sales, $
Annual net income, $
Number of employees
Problem or Opportunity
According to the data of the World Health Organization (WHO), the first reason for the errors made in the diagnosis of the disease originates from the general practitioners. When compared to all other reasons, it draws attention with a rate of 79%. One of the reasons for this is that these physicians, who are not classified as specialist physicians, encounter diseases of all branches. Another reason is that newly graduated (inexperienced) physicians start their duties as general practitioners. According to the 2018 data of the World Health Organization (WHO), the total number of general practitioners in Turkey is 44,311. The World Health Organization (WHO) offers some suggestions for the solution in the analysis report of the errors made in the diagnosis of the disease, which it shared in 2016. WHO states that the solution lies in systems that offer differential diagnosis. Sanalkons offers physicians the opportunity to enter more than 18000 data in 24 different categories (Family History, Laboratory, Signs, And Symptoms, etc.). It shares the most appropriate results among 8500 differential diagnoses thanks to the user's data.
Source: Diagnostic Errors: Technical Series on Safer Primary Care
Solution (product or service)
We have a strong medical content production team with 6 doctors and 7 volunteer medical students. This team has the ability to renew and edit the content on the medical algorithm. Therefore, any problems that may arise will be solved by our own team. In addition, there are 1 full-time and 2 part-time software developers in our team. Technical problems that may occur will be solved by our software team in a short time.
The closest product to our system is Isabel of the three other online clinical decision support systems Isabel, RAMP, and Cohesic. Some of our distinguishing features from this product; Our location is integrated and we share real-time public health data with the physician. Together with the public health data, it is ensured that the physician focuses on the most accurate differential diagnoses. For example, increased diarrhea data in the patient's location may lead the doctor to a diagnosis of drinking water poisoning in that region. Or, a newly emerged fever in that area may reflect a different epidemic situation. Thus, epidemic disease situations that can be prevented with early diagnosis and treatment are presented to the general practitioners to whom the first application is made.
Advantages or differentiators
The advantages and differentiators
The most comprehensive 'online’ CDSS(Clinical decision support system) in the World
The only location integrated CDSS
Real-time single CDSS
The most comprehensive algorithm known
Our product is sold to individual users with an annual subscription. The annual subscription price is $69. We aim to have 33% of general practitioners subscribe to the system in the first year. In the 2nd year, we aim to reach 70% of general practitioners in Turkey and 20% of users in Europe. In the 3rd year, we are targeting new users from different countries out of Europe. The number of users we aim to reach in the 5th year is 500000.
Our product is sold to individual users with an annual subscription. The annual subscription price is $69.
Reason for sale
Entering the foreign market
To make our current team structure permanent
To turn our system offered on the web into a multilingual android and ios supported application
Advertisement and marketing
According to the World Health Organization (WHO) 2018 data, the number of general practitioners in Turkey is 44,311. Our first target is local users. Our next target is general practitioner users in Europe. According to the 2018-2019 data of the World Health Organization (WHO), the number of general practitioners in Europe is 550,000. The global market title, which includes the sanal.clinic system that is integrated with Sanalkons and Sanalkons, is health tech. The expected volume of this market for 2025 is 380 billion dollars.
Increasing the number of competitors.
Solution; Thanks to 2.5 years of algorithm work, our algorithm accuracy rate is increasing day by day with dynamic infrastructure and artificial intelligence solutions. For this reason, we aim to dominate the market with performance higher than our competitors.